Soon Dong Lee | Taxonomy of Microbes | Best Researcher Award

Dr. Soon Dong Lee | Taxonomy of Microbes | Best Researcher Award

Institute of Jeju Microbial Resources, BIOPS Co., Ltd | South Korea

Dr. Soon Dong Lee has made significant contributions to the field of microbiology, particularly in microbial taxonomy, antibiotic biosynthesis, and actinomycete research. His early research explored the biochemical relationships between methionine metabolism and tylosin biosynthesis in Streptomyces fradiae, advancing understanding of antibiotic production pathways in industrially important microorganisms. During his doctoral work, he conducted extensive studies on the classification and characterization of novel actinomycetes isolated from a gold mine cave in Kongju, Korea, contributing to the discovery and taxonomic differentiation of new microbial species with potential biotechnological applications. As a researcher at the Research Center for Molecular Microbiology, he focused on molecular mechanisms governing microbial diversity and secondary metabolite synthesis. His postdoctoral studies further deepened his expertise in microbial genetics and systematics, emphasizing the ecological and functional roles of actinomycetes in natural environments. Later, as a research associate at the University of Minnesota, he extended his investigations into plant-microbe interactions and microbial pathogenesis, integrating molecular microbiology with plant pathology. Through his multidisciplinary research, Dr. Lee has enhanced scientific understanding of microbial taxonomy, secondary metabolism, and the potential of actinomycetes in biotechnology and agriculture.

Profile: Orcid

Featured Publications:

Kim, S. B., Lee, S. D., Kim, S. Y., Oh, H. H., Kang, S.-O., & Hah, Y. C. (1996). Numerical classification of actinomycetes isolated from volcanic soil. Journal of Microbiology, 34(2), 105–116.

Seong, C. N., Kim, Y. S., Baik, K. S., Lee, S. D., Hah, Y. C., Kim, S. B., & Goodfellow, M. (1999). Mycolic acid-containing actinomycetes associated with activated sludge foam. Journal of Microbiology, 37(2), 66–72.

Lee, S. D., Goodfellow, M., & Hah, Y. C. (1999). A phylogenetic analysis of the genus Catellatospora based on 16S ribosomal DNA sequences, including transfer of Catellatospora matsumotoense to the genus Micromonospora as Micromonospora matsumotoense comb. nov. FEMS Microbiology Letters, 178(2), 349–354.

Lee, S. D., Kim, E. S., & Hah, Y. C. (2000). Phylogenetic analysis of the genera Pseudonocardia and Actinobispora based on 16S ribosomal DNA sequences. FEMS Microbiology Letters, 182(1), 125–129.

Lee, S. D., Kang, S.-O., & Hah, Y. C. (2000). Hongia gen. nov., a new genus of the order Actinomycetales. International Journal of Systematic and Evolutionary Microbiology, 50(1), 191–199.

Lee, S. D., Kang, S.-O., & Hah, Y. C. (2000). Catellatospora koreensis sp. nov., a novel actinomycete isolated from a gold-mine cave. International Journal of Systematic and Evolutionary Microbiology, 50(3), 1103–1111.

Lee, S. D., Kim, E. S., Roe, J.-H., Kim, J.-H., Kang, S.-O., & Hah, Y. C. (2000). Saccharothrix violacea sp. nov., isolated from a gold mine cave, and Saccharothrix albidocapillata comb. nov. International Journal of Systematic and Evolutionary Microbiology, 50(3), 1315–1323.

Weiping Qin | Spinal Cord Injury | Best Researcher Award

Prof. Dr. Weiping Qin | Spinal Cord Injury | Best Researcher Award

The Icahn School of Medicine at Mount Sinai/James J. Peters VAMC | United States

Dr. Weiping Qin’s research focuses on developing innovative therapeutic strategies to prevent and reverse skeletal and neurological impairments associated with spinal cord injury (SCI). His laboratory investigates the molecular and cellular mechanisms underlying bone loss, muscle atrophy, and neurodegeneration following SCI, with the goal of identifying novel molecular targets for treatment. Dr. Qin’s work integrates approaches from molecular biology, neuroscience, and regenerative medicine to elucidate how injury-induced changes in signaling pathways, inflammation, and oxidative stress contribute to tissue degeneration. He also explores pharmacological and biological interventions that may enhance neural repair, bone regeneration, and functional recovery. Through translational studies, his team aims to bridge fundamental discoveries with clinical applications, advancing potential therapies to improve quality of life and outcomes for patients with SCI. His research has been recognized for its contributions to understanding neurodegenerative and skeletal pathology, and for identifying key therapeutic avenues to promote tissue protection and regeneration.

Profiles:  Google Scholar | Scopus

Featured Publications:

Qin, W., Ho, L., Pompl, P. N., Xiang, Z., Wang, J., Zhao, Z., Peng, Y., Cambareri, G., & others. (2004). Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer’s disease. The FASEB Journal, 18(7), 902–904.

Qin, W., Yang, T., Ho, L., Zhao, Z., Wang, J., Chen, L., Zhao, W., Thiyagarajan, M., & others. (2006). Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. Journal of Biological Chemistry, 281(31), 21745–21754.

Qin, W., Haroutunian, V., Katsel, P., Cardozo, C. P., Ho, L., Buxbaum, J. D., & others. (2009). PGC-1α expression decreases in the Alzheimer disease brain as a function of dementia. Archives of Neurology, 66(3), 352–361.

Wang, J., Ho, L., Qin, W., Rocher, A. B., Seror, I., Humala, N., Maniar, K., Dolios, G., & others. (2005). Caloric restriction attenuates β-amyloid neuropathology in a mouse model of Alzheimer’s disease. The FASEB Journal, 19(6), 1–18.

Yamashita, T., Kaneko, S., Shirota, Y., Qin, W., Nomura, T., Kobayashi, K., & others. (1998). RNA-dependent RNA polymerase activity of the soluble recombinant hepatitis C virus NS5B protein truncated at the C-terminal region. Journal of Biological Chemistry, 273(25), 15479–15486.

Shirota, Y., Luo, H., Qin, W., Kaneko, S., Yamashita, T., Kobayashi, K., & others. (2002). Hepatitis C virus (HCV) NS5A binds RNA-dependent RNA polymerase (RdRP) NS5B and modulates RNA-dependent RNA polymerase activity. Journal of Biological Chemistry, 277(13), 11149–11155.

Lin Teng | Cell Junction Complexes | Best Researcher Award

Dr. Lin Teng | Cell Junction Complexes | Best Researcher Award

Yichang Central People’s Hospital | China

Dr. Lin Teng is a distinguished cardiovascular researcher whose work focuses on the molecular mechanisms underlying cardiac electrophysiological dysfunction and vascular remodeling. His research primarily explores the pathophysiological basis of heart rhythm disorders and ischemic heart disease, emphasizing the roles of ion channels and cellular stress responses in cardiac function. One of his major studies investigates the mechanism of HCN4-mediated electrophysiological dysfunction in acute sinoatrial node ischemia, contributing to a deeper understanding of arrhythmogenesis and potential therapeutic targets. Additionally, his research on C/EBP homologous protein-10 elucidates its role in vascular remodeling and restenosis following percutaneous transluminal coronary angioplasty (PTCA), providing insights into post-interventional vascular repair mechanisms. Another key area of his investigation involves the glutamate autocrine circuit in embryonic stem cells and its regulatory role in cardiomyocyte differentiation, offering potential applications in regenerative cardiology. Supported by multiple provincial and municipal grants, Dr. Teng’s studies integrate pharmacological, molecular, and clinical perspectives to advance cardiovascular medicine. His contributions have been recognized through prestigious science and technology awards, underscoring his impact on translational cardiovascular research and clinical innovation.

Profile: Orcid

Featured Publications:

Zhou, Z., Qin, Q., Dong, C., & Teng, L. (2025). The dual guardians of cellular stability: Exploring nesprin and lamin in senescence. Cell Death & Disease, 16, 757.

Liu, Y., Qin, Q., Zhou, Z., Zhou, F., & Teng, L. (2025). Treatment of coronary arteriovenous fistula with patent ductus arteriosus occluder: A case report. British Journal of Hospital Medicine (London), 86(5), 1–9.

Yang, Y., Min, Z., Ye, Y., Teng, L., Cao, C., Li, W., Wen, T., Li, S., Ding, J., Yang, J., & Zhou, F. (2025). A new model for the prediction of intramyocardial hemorrhage in ST-segment elevation myocardial infarction patients after emergency percutaneous coronary intervention. Catheterization and Cardiovascular Interventions. Advance online publication. ht

Qin, Q., Zhou, Z. Y., Liu, Y., Zhou, F., Cao, C., & Teng, L. (2024). Unraveling the nexus of nesprin in dilated cardiomyopathy: From molecular insights to therapeutic prospects. Life Sciences, 358, 123126.

Teng, L., Zhou, F., Xiong, X., Zhang, H., Qiao, L., Zhang, Z., Qin, Q., & Song, X. (2024). Minimally invasive palliative treatment of malignant tracheoesophageal fistula using cardiac septal occluder. Langenbeck’s Archives of Surgery, 409(1), 169.

Saeed Banaeian Far | Biological Metaverse | Pioneer Researcher Award

Assist. Prof. Dr. Saeed Banaeian Far | Biological Metaverse | Pioneer Researcher Award

Blockchain and Metaverse Research Lab | Iran

Dr. Saeed Banaeian Far is a senior researcher specializing in applied cryptography, blockchain-based security protocols, and privacy-preserving systems. His current postdoctoral research at Yazd University, supported by the Iran National Science Foundation (INSF), focuses on developing collaboration methods for digital twin teams across heterogeneous blockchains without centralized authority. He earned his Ph.D. in Electrical Engineering with a specialization in Communication Systems and Cryptography, where his dissertation proposed novel approaches to enhancing security and privacy in blockchain-based data auditing protocols. His research output includes over 40 published articles and approximately 20 ongoing manuscripts, demonstrating a strong commitment to advancing blockchain interoperability, secure communication networks, and metaverse-related applications such as the BioVerse. Dr. Banaeian Far has also contributed as a reviewer for multiple academic journals and conferences in the fields of cybersecurity and distributed systems. His recent work on cross-chain frameworks for digital twin interoperability earned him the Best Paper Award at the 11th International Conference on Web Research (ICWR2025). With a research focus that bridges cryptographic theory and real-world decentralized systems, he continues to contribute to the development of secure, scalable, and privacy-aware blockchain infrastructures.

Profiles: Google Scholar | Scopus | Orcid

Featured Publications:

Banaeian Far, S., & Imani Rad, A. (2022). Applying digital twins in Metaverse: User interface, security and privacy challenges. Journal of Metaverse, 2(1), 8–16.

Banaeian Far, S., Imani Rad, A., & Rajabzadeh Asaar, M. (2023). Blockchain and its derived technologies shape the future generation of digital businesses: A focus on decentralized finance and the Metaverse. Data Science and Management, 6(3), 183–197.

Banaeian Far, S., Imani Rad, A., Hosseini Bamakan, S. M., & others. (2023). Toward Metaverse of everything: Opportunities, challenges, and future directions of the next generation of visual/virtual communications. Journal of Network and Computer Applications, 103675.

Banaeian Far, S., Hosseini Bamakan, S. M., Qu, Q., & Jiang, Q. (2022). A review of non-fungible token applications in the real world and Metaverse. Procedia Computer Science, 214, 755–762.

Banaeian Far, S., & Hosseini Bamakan, S. M. (2023). NFT-based identity management in Metaverses: Challenges and opportunities. SN Applied Sciences, 5(10), 260.

Banaeian Far, S., & Hosseini Bamakan, S. M. (2022). Blockchain-based reporting protocols as a collective monitoring mechanism in DAOs. Data Science and Management, 5(1), 11–12.

Hamidreza Mohammadi | Toxicology and Pharmacology | Best Researcher Award

Prof. Hamidreza Mohammadi | Toxicology and Pharmacology | Best Researcher Award

Mazandaran University of Medical Sciences, Sari, Iran

Dr. Hamidreza Mohammadi is a researcher specializing in toxicology, pharmacology, and nanomedicine, with extensive work focused on the toxicological and therapeutic applications of nanomaterials. His research spans multiple domains including nanotoxicology, polymer therapeutics, clinical and food toxicology, and the development of safer nanopharmaceuticals. He has contributed to advancing the understanding of how engineered nanomaterials interact with biological systems, emphasizing risk assessment, cellular mechanisms of toxicity, and strategies for biocompatibility improvement. Dr. Mohammadi’s studies also explore the design of polymer-based drug delivery systems with enhanced therapeutic efficacy and reduced side effects. His work integrates experimental and applied toxicology to bridge laboratory research with clinical practice, contributing to public health and safety in pharmacological sciences. With interdisciplinary expertise covering both environmental and clinical toxicology, his research aligns with global priorities in nanomedicine innovation and toxicological risk evaluation. His scholarly efforts continue to support the development of next-generation nanotherapeutics with optimized pharmacokinetics and minimized toxic responses, reinforcing the importance of safe and sustainable nanotechnology in medical and pharmaceutical applications.

Profile: Orcid

Featured Publications:

Mokhtari Azad, T., Mohammadi, H., Moosavi, A., Saadatmand, Z., & Nategh, R. (2004). Influenza surveillance in the Islamic Republic of Iran from 1991 to 2001. Eastern Mediterranean Health Journal, 10(3), 315–321.

Cheraghali, A. M., Mohammadi, H. R., Amirahmadi, M., Yazdanpanah, H., Abouhossain, G., & Zamanian, F. (2005). Incidence of patulin contamination in apple juice produced in Iran. Food Control, 16(2), 165–167.

Shafiee, H., Mohammadi, H., Rezayat, S. M., Hosseini, A., Baeeri, M., & Hassani, S. (2010). Prevention of malathion-induced depletion of cardiac cells mitochondrial energy and free radical damage by a magnetic magnesium-carrying nanoparticle. Toxicology Mechanisms and Methods, 20(9), 538–543.

Mohammadi, H., Karimi, G., Rezayat, S. M., Reza, A., Shafiee, H., & Nikfar, S. (2011). Benefit of nanocarrier of magnetic magnesium in rat malathion-induced toxicity and cardiac failure using non-invasive monitoring of electrocardiogram and blood pressure. Toxicology and Industrial Health, 27(5), 417–429.

Soltani, M., Shetab-Boushehri, S. F., Mohammadi, H., & Shetab-Boushehri, S. V. (2013). Proposing boric acid as an antidote for aluminium phosphide poisoning by investigation of the chemical reaction between boric acid and phosphine. Journal of Medical Hypotheses and Ideas, 7(1), 21–24.

Nestor Garcia | Cellular Stress Response | Best Academic Researcher Award

Prof. Dr. Nestor Garcia | Cellular Stress Response | Best Academic Researcher Award

CONICET | Argentina

Dr. Néstor Horacio García, MD, PhD, is a physician-scientist specializing in nephrology and vascular research with a strong focus on renal physiology, hypertension, and phosphate homeostasis. He earned his medical and doctoral degrees from the National University of Córdoba, complemented by advanced research training at the Henry Ford Hospital in the United States, where he investigated mechanisms related to hypertension and vascular regulation. His postdoctoral fellowship at the Mayo Foundation in Rochester, Minnesota, further deepened his expertise in phosphate metabolism and kidney function. Dr. García has served as a Research Clinical Associate in the Nephrology Department at Sanatorium Mayo, Córdoba, where he has acted as Principal Investigator for multiple pharmaceutical protocols and clinical studies. He has also contributed to Inspiranox Therapeutics Corporation as a medical scientist and clinical research consultant, engaging in translational and therapeutic innovation. His research explores the pathophysiology of kidney disease, the molecular regulation of blood pressure, and protective mechanisms against diabetic renal dysfunction. Recognized nationally and internationally, Dr. García has received multiple awards for excellence in basic nephrology research, including honors from the Argentine Society of Hypertension and the Latin American Society of Nephrology and Hypertension (SLANH).

Profile: Orcid

Featured Publications:

García, N. H. (2021). An intensive follow-up in subjects with cardiometabolic high-risk. Nutrition, Metabolism and Cardiovascular Diseases.

García, N. H. (2021). Effect of SGLT2 inhibitors on stroke and atrial fibrillation in diabetic kidney disease. Stroke, 52(5), e125–e132.

García, N. H. (2020). Monosialoganglioside GM1 reduces toxicity of Ptx and increases anti-metastatic effect in a murine mammary cancer model. Scientific Reports, 10(1), 10645.

García, N. H. (2020). Ibuprofen, a traditional drug that may impact the course of COVID-19: New effective formulation in nebulizable solution. Medical Hypotheses, 144, 110079.

García, N. H. (2020). Eicosapentaenoic acid prevents salt sensitivity in diabetic rats and decreases oxidative stress. Nutrition, 79–80, 110644.

Borros Arneth | Pathobiochemistry | Outstanding Scientist Award

Dr. Borros Arneth | Pathobiochemistry | Outstanding Scientist Award

Justus Liebig University Giessen and Philipps University Marburg Germany | Germany

Dr. Borros Michael Arneth is a medical researcher specializing in clinical chemistry, laboratory medicine, molecular diagnostics, and pathobiochemistry. His academic foundation was established at the Johann Wolfgang Goethe University in Frankfurt am Main, where he studied biochemistry and human medicine. His doctoral research focused on magnetic resonance spectroscopic investigations of fatty acid-binding proteins (FABP) in HIV patients, contributing to the understanding of biochemical alterations in neurodegenerative and infectious diseases. Over his career, Dr. Arneth has served as a research assistant and later as a senior physician at leading institutions, including the Carl Gustav Carus University Hospital in Dresden and the University Hospital Mainz. His expertise extends to areas such as clinical biochemistry, immunology, and medical microbiology. He has achieved recognition as a European Specialist in Clinical Chemistry and Laboratory Medicine (EurClinChem) and has been actively involved in scientific publishing as an editor and reviewer for multiple international journals, including Clinical Biochemistry and the International Journal of Immunology. His research emphasizes biochemical mechanisms underlying disease processes, molecular diagnostics, and advancements in laboratory medicine for clinical applications.

Profiles: Google Scholar | Orcid

Featured Publications:

Arneth, B., Arneth, R., & Shams, M. (2019). Metabolomics of type 1 and type 2 diabetes. International Journal of Molecular Sciences, 20(10), 2467.

Shams, M. E. E., Arneth, B., Hiemke, C., Dragicevic, A., Müller, M. J., Kaiser, R., & others. (2006). CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine. Journal of Clinical Pharmacy and Therapeutics, 31(5), 493–502.

Arneth, B. (2018). Update on the types and usage of liquid biopsies in the clinical setting: A systematic review. BMC Cancer, 18(1), 527.

Arneth, B. M. (2019). Impact of B cells to the pathophysiology of multiple sclerosis. Journal of Neuroinflammation, 16(1), 128.

Ali Esmaeili | Cellular Senescence Aging | Best Researcher Award

Assoc. Prof. Dr. Ali Esmaeili | Cellular Senescence Aging | Best Researcher Award

Allameh Tabatabai | Iraq

Associate Professor Dr. Ali Esmaeili’s research primarily focuses on the psychological and cognitive dimensions of sports science and human movement behavior. His extensive body of work explores how emotional regulation, motivation, and social skills influence executive functions and overall well-being among students and athletes. Esmaeili has investigated the mediating role of emotional regulation in the relationship between social skills and executive functioning, as well as the cognitive benefits of game-based sports exercises for late learners. His studies also examine how sports participation enhances social identity and well-being, particularly among female students. Beyond educational contexts, Esmaeili’s research extends to clinical and developmental psychology, addressing topics such as attention-deficit/hyperactivity disorder, separation anxiety, and emotion regulation in families with children with autism. He has further contributed to understanding attentional bias modification, forgiveness therapy, and hypnosis as psychological interventions for improved mental health and performance. His publications span multiple interdisciplinary journals, bridging physical education, cognitive psychology, and behavioral sciences, highlighting his commitment to integrating psychological frameworks into sports and movement studies. Collectively, Esmaeili’s research advances knowledge in sport psychology, emphasizing emotional and cognitive development through structured physical activity and psychological skill training.

 Profile: Scopus

Featured Publications:

Esmaeili, A. (2025). Exploring factors influencing sustainable behaviors in undergraduate students’ sports participation through model development and validation. Scientific Reports.

Esmaeili, A. (2024). The mediating role of emotional regulation skills in the relationship between social skills with executive functions of students. Modern Psychological Research.

Esmaeili, A. (2024). Effect of game-based sports exercises on high-level cognitive processes of late learners. Cognition Behavior Learning Journal.

Esmaeili, A. (2024). The role of motivating sports participation in the social well-being and social identity of female students of the first secondary school of knowledge in rural Jajarm City. Psychology of Development (Royeshe-Ravanshenasi).

Georgios Karras | Protein Folding Chaperones | Best Researcher Award

Assoc. Prof. Dr. Georgios Karras | Protein Folding Chaperones | Best Researcher Award

The University of Texas MD Anderson Cancer Center | United States

Dr. Georgios Karras is a molecular geneticist whose research focuses on understanding cellular stress responses and genome stability mechanisms, with implications for cancer development and therapy. His work explores how cells maintain protein homeostasis and genomic integrity under physiological and pathological stress, integrating molecular genetics, biochemistry, and systems biology approaches. Through his research, Dr. Karras investigates molecular pathways that regulate proteostasis, DNA repair, and chromatin dynamics, aiming to uncover how their dysregulation contributes to tumorigenesis. His studies have advanced understanding of the molecular mechanisms that link protein quality control systems to genome maintenance, providing insights into how stress adaptation influences cancer cell survival and progression. Dr. Karras’s laboratory also develops innovative genetic and biochemical models to study these processes, combining yeast and mammalian systems to identify conserved stress response mechanisms. His research has received recognition through multiple national awards and funding programs, including support from cancer research foundations and the National Cancer Institute. By elucidating the interplay between cellular stress signaling and genome stability, Dr. Karras’s work contributes to the development of novel strategies for targeting stress-related vulnerabilities in cancer cells, offering new perspectives for precision oncology and therapeutic interventions.

Profiles: Scopus | Orcid

Featured Publications:

Gracia, B., Zhang, X. H., Montes, P., Pham, T. C., Huang, M., Chen, J., & Karras, G. I. (2024). HSP90 buffers deleterious genetic variations in BRCA1. bioRxiv [Preprint].

Karras, G. I., Colombo, G., & Kravats, A. N. (2025). Hsp90: Bringing it all together. Cell Stress & Chaperones, 30(1), 69–79.

Condic, N., Amiji, H., Patel, D., Shropshire, W., Lermi, N. O., Sabha, Y., John, B., Hanson, B., & Karras, G. I. (2024). Selection for robust metabolism in domesticated yeasts is driven by adaptation to Hsp90 stress. Science, 385(6707), eadi3048.

Gracia, B., Montes, P., Gutierrez, A. M., Arun, B., & Karras, G. I. (2024). Protein-folding chaperones predict structure-function relationships and cancer risk in BRCA1 mutation carriers. Cell Reports, 43(2), 113803.

Carter, B. Z., Mak, P. Y., Muftuoglu, M., Tao, W., Ke, B., Pei, J., Bedoy, A. D., Ostermann, L. B., Nishida, Y., Isgandarova, S., Sobieski, M., Nguyen, N., Powell, R. T., Martinez-Moczygemba, M., Stephan, C., Basyal, M., Pemmaraju, N., Boettcher, S., Ebert, B. L., … Karras, G. I. (2023). Epichaperome inhibition targets TP53-mutant AML and AML stem/progenitor cells. Blood, 142(12), 1056–1070.

Katia Figueiredo | Intracellular Transport Systems | Innovative Research Award

Prof. Dr. Katia Figueiredo | Intracellular Transport Systems | Innovative Research Award

Universidade Federal de Minas Gerais | Brazil

Professor Kátia Cecília de Souza Figueiredo is a researcher in Chemical Engineering with expertise in membrane separation processes and adsorption technologies. Her work primarily focuses on gas separation and protein recovery from food residues, integrating principles of transport phenomena, materials science, and bioprocessing. She has contributed significantly to the development and optimization of advanced membrane materials and adsorption systems for sustainable industrial applications. Her recent studies include the continuous adsorption and desorption of model proteins using chitosan beads and the creation of oxygen-functionalized carbon nanotube composites in polysulfone matrices for efficient CO₂ separation. She has also explored innovative approaches for downstream butanol separation from ABE fermentation, as well as protein recovery processes such as bromelain extraction from pineapple subproducts using ultrafiltration and aqueous biphasic systems. Earlier in her career, she developed crosslinked poly(vinyl alcohol) films with improved stability under mild reaction conditions. Her research integrates green engineering approaches with process intensification, aiming to enhance efficiency, reduce waste, and promote the use of renewable materials. Overall, her work contributes to advancing sustainable separation technologies and bioprocess engineering in chemical and environmental applications.

Profiles: Scopus | Orcid

Featured Publications:

Figueiredo, K. C. S., & [Co-authors]. (2024). Mixed matrix membranes of polydimethylsiloxane with activated carbon for ABE separation. Journal of Applied Polymer Science.

[Author(s)]. (2024). Selection criteria for solvent and coagulation medium to modulate the structure of polymethylmethacrylate prepared by wet phase inversion. Orbital.

Flores, M. C., & Figueiredo, K. C. S. (2023). Asymmetric oxygen-functionalized carbon nanotubes dispersed in polysulfone for CO₂ separation. Journal of Applied Polymer Science.